Laxmi Dental Ltd.
•₹ 198.14-0.02%
2026-08-21
PROS
- Company is almost debt free
- Operating margins have improved to 15.6% from 6.9%
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.89x)
CONS
- Recent results are weak - TTM profit is down 29.7% versus prior year
- Company has a low return on capital employed of 11.0%
- Working capital days have increased from 62 to 294 days
- Stock is trading at 11.1x its book value
- Rich enterprise valuation - EV/EBITDA of 74.3x
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | LENSKART | 639.30 | 169.67 | 111193.84 | 0.00 | 2284.30 | 3634.35 | 27141.80 | 1332.69 | 12.55 | 21.70 |
| 2. | POLYMED | 1771.60 | 56.99 | 17957.20 | 0.20 | 85.27 | -8.39 | 525.38 | 30.30 | 14.05 | 24.11 |
| 3. | MOLBIO | 1040.35 | 71.97 | 11988.99 | 0.00 | — | — | — | — | 19.79 | — |
| 4. | LAXMIDENTL | 195.65 | 34.85 | 1076.50 | 0.00 | 10.32 | 23.83 | 74.70 | 16.13 | 24.96 | 20.26 |
| 5. | 3BBLACKBIO | 1145.55 | 17.71 | 983.19 | 0.44 | 8.98 | -28.99 | 33.49 | 50.59 | 26.03 | 25.45 |
| 6. | GKB | 63.95 | 9.94 | 32.23 | 0.00 | 1.85 | 387.99 | 33.04 | 2.26 | 8.82 | 7.97 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 34 | 39 | 43 | 42 | 43 | 42 | 50 | 54 | 48 | 55 | 55 | |
| 34 | 33 | 35 | 37 | 38 | 35 | 40 | 47 | 44 | 48 | 50 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 3 |
| -1 | 4 | 13 | 3 | 3 | 6 | 9 | 7 | -2 | 7 | 8 | |
| Tax % | 86.13% | 13.70% | 9.10% | 35.43% | 26.35% | 46.41% | 24.00% | 23.63% | -55.85% | -5.78% | 22.28% |
| Net Profit | -0 | 4 | 11 | 2 | 2 | 3 | 7 | 6 | -3 | 7 | 6 |
| 0 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | -0 | 1 | 0 | |
| Equity Capital | 0 | 0 | 6 | 6 | 10 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 0 | 0 | 6 | 6 | 10 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Dec 2023
- 34
- 34
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- -1
- Tax %
- 86.13%
- Net Profit
- -0
- 0
- Equity Capital
- 0
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 0
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 39
- 33
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 2
- 4
- Tax %
- 13.70%
- Net Profit
- 4
- 1
- Equity Capital
- 0
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 0
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 43
- 35
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 13
- Tax %
- 9.10%
- Net Profit
- 11
- 3
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 42
- 37
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 35.43%
- Net Profit
- 2
- 1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 43
- 38
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 3
- 3
- Tax %
- 26.35%
- Net Profit
- 2
- 1
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 42
- 35
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 3
- 6
- Tax %
- 46.41%
- Net Profit
- 3
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 50
- 40
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 2
- 9
- Tax %
- 24.00%
- Net Profit
- 7
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 54
- 47
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- 7
- Tax %
- 23.63%
- Net Profit
- 6
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 48
- 44
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- -2
- Tax %
- -55.85%
- Net Profit
- -3
- -0
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 55
- 48
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- 7
- Tax %
- -5.78%
- Net Profit
- 7
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 55
- 50
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- 8
- Tax %
- 22.28%
- Net Profit
- 6
- 0
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 113 | 126 | 139 | 171 | 212 | |
| 109 | 120 | 128 | 145 | 188 | |
| Operating Profit | 8 | 14 | 17 | 31 | — |
| OPM % | 7 | 11 | 12 | 18 | — |
| Other Income | 4 | 8 | 5 | 5 | 8 |
| Interest | 3 | 4 | 5 | 4 | 1 |
| Depreciation | 7 | 9 | 9 | 10 | 12 |
| -2 | 1 | 3 | 24 | 20 | |
| Tax % | -119 | 1 | -323 | 24 | 21 |
| Net Profit | -4 | 1 | 14 | 19 | 16 |
| EPS | -144 | 0 | 443 | 3 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | -0 | 1 | 9 | 7 | 1 |
| Adjusted EPS | -2 | 0 | 5 | 3 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | -0 | 1 | 9 | 7 | 1 |
| Adjusted EPS | -2 | 0 | 5 | 3 | — |
Mar 2022
- 113
- 109
- Operating Profit
- 8
- OPM %
- 7
- Other Income
- 4
- Interest
- 3
- Depreciation
- 7
- -2
- Tax %
- -119
- Net Profit
- -4
- EPS
- -144
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- -2
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- -2
Mar 2023
- 126
- 120
- Operating Profit
- 14
- OPM %
- 11
- Other Income
- 8
- Interest
- 4
- Depreciation
- 9
- 1
- Tax %
- 1
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 1
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 1
- Adjusted EPS
- 0
Mar 2024
- 139
- 128
- Operating Profit
- 17
- OPM %
- 12
- Other Income
- 5
- Interest
- 5
- Depreciation
- 9
- 3
- Tax %
- -323
- Net Profit
- 14
- EPS
- 443
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 9
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 9
- Adjusted EPS
- 5
Mar 2025
- 171
- 145
- Operating Profit
- 31
- OPM %
- 18
- Other Income
- 5
- Interest
- 4
- Depreciation
- 10
- 24
- Tax %
- 24
- Net Profit
- 19
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 7
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 7
- Adjusted EPS
- 3
TTM
- 212
- 188
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 1
- Depreciation
- 12
- 20
- Tax %
- 21
- Net Profit
- 16
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 1
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 1
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 15%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -43%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 17%
- Last Year:
- 14%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| 0 | 0 | 0 | 11 | |
| 36 | 28 | 51 | 210 | |
| 14 | 19 | 20 | 0 | |
| Trade Payables | 17 | 18 | 11 | 29 |
| 38 | 42 | 38 | 17 | |
| Total Liabilities | 106 | 108 | 121 | 267 |
| ASSETS | - | - | - | - |
| 32 | 34 | 32 | 40 | |
| 17 | 14 | 14 | 17 | |
| 23 | 20 | 23 | 17 | |
| 0 | 0 | 34 | 32 | |
| Cash & Bank | 1 | 1 | 0 | 107 |
| 33 | 39 | 18 | 55 | |
| Total Assets | 106 | 108 | 121 | 267 |
| Total Debt | 29 | 31 | 38 | 0 |
| Net Working Capital | 9 | 8 | 24 | 138 |
| Contingent Liabilities | 0 | 0 | 4 | 4 |
| Book Value per Share | 1165.06 | 923.99 | 1673.83 | 40.13 |
| Face Value | 10.00 | 10.00 | 10.00 | 2.00 |
| Total Debt | 29 | 31 | 38 | 0 |
| Net Working Capital | 9 | 8 | 24 | 138 |
| Contingent Liabilities | 0 | 0 | 4 | 4 |
| Book Value per Share | 1165.06 | 923.99 | 1673.83 | 40.13 |
| Face Value | 10.00 | 10.00 | 10.00 | 2.00 |
Mar 2022
- 0
- 36
- 14
- Trade Payables
- 17
- 38
- Total Liabilities
- 106
- 32
- 17
- 23
- 0
- Cash & Bank
- 1
- 33
- Total Assets
- 106
- Total Debt
- 29
- Net Working Capital
- 9
- Contingent Liabilities
- 0
- Book Value per Share
- 1165.06
- Face Value
- 10.00
- Total Debt
- 29
- Net Working Capital
- 9
- Contingent Liabilities
- 0
- Book Value per Share
- 1165.06
- Face Value
- 10.00
Mar 2023
- 0
- 28
- 19
- Trade Payables
- 18
- 42
- Total Liabilities
- 108
- 34
- 14
- 20
- 0
- Cash & Bank
- 1
- 39
- Total Assets
- 108
- Total Debt
- 31
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 923.99
- Face Value
- 10.00
- Total Debt
- 31
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 923.99
- Face Value
- 10.00
Mar 2024
- 0
- 51
- 20
- Trade Payables
- 11
- 38
- Total Liabilities
- 121
- 32
- 14
- 23
- 34
- Cash & Bank
- 0
- 18
- Total Assets
- 121
- Total Debt
- 38
- Net Working Capital
- 24
- Contingent Liabilities
- 4
- Book Value per Share
- 1673.83
- Face Value
- 10.00
- Total Debt
- 38
- Net Working Capital
- 24
- Contingent Liabilities
- 4
- Book Value per Share
- 1673.83
- Face Value
- 10.00
Mar 2025
- 11
- 210
- 0
- Trade Payables
- 29
- 17
- Total Liabilities
- 267
- 40
- 17
- 17
- 32
- Cash & Bank
- 107
- 55
- Total Assets
- 267
- Total Debt
- 0
- Net Working Capital
- 138
- Contingent Liabilities
- 4
- Book Value per Share
- 40.13
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 138
- Contingent Liabilities
- 4
- Book Value per Share
- 40.13
- Face Value
- 2.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -4 | 10 | 5 | 47 | |
| Cash from Investing | 3 | -6 | -6 | -49 |
| Cash from Financing | 1 | -1 | -2 | 104 |
| -1 | 3 | -3 | 102 | |
| Free Cash Flow | -4 | 10 | -2 | 32 |
| OCF / Net Profit | 1.01 | 17.69 | 0.37 | 2.53 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
| OCF / Net Profit | 1.01 | 17.69 | 0.37 | 2.53 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
Mar 2022
- -4
- Cash from Investing
- 3
- Cash from Financing
- 1
- -1
- Free Cash Flow
- -4
- OCF / Net Profit
- 1.01
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.01
- Cumulative 5-Year FCF
- 0
Mar 2023
- 10
- Cash from Investing
- -6
- Cash from Financing
- -1
- 3
- Free Cash Flow
- 10
- OCF / Net Profit
- 17.69
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 17.69
- Cumulative 5-Year FCF
- 0
Mar 2024
- 5
- Cash from Investing
- -6
- Cash from Financing
- -2
- -3
- Free Cash Flow
- -2
- OCF / Net Profit
- 0.37
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.37
- Cumulative 5-Year FCF
- 0
Mar 2025
- 47
- Cash from Investing
- -49
- Cash from Financing
- 104
- 102
- Free Cash Flow
- 32
- OCF / Net Profit
- 2.53
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.53
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| PER SHARE | - | - | - | - |
| EPS (₹) | -142.51 | 18.21 | 442.95 | 3.39 |
| Book Value (₹) | 1165.06 | 923.99 | 1673.83 | 40.13 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.88 | 3.59 | 8.21 | 5.17 |
| PROFITABILITY | - | - | - | - |
| Operating Margin % | 6.89% | 11.13% | 8.34% | 15.58% |
| Net Margin % | -3.89% | 0.45% | 9.79% | 10.87% |
| ROE % | -12.23% | 1.74% | 34.10% | 13.68% |
| ROCE % | 1.23% | 6.25% | 9.07% | 17.68% |
| -4.15% | 0.53% | 11.94% | 9.59% | |
| EFFICIENCY | - | - | - | - |
| Debtor Days | 73 | 75 | 82 | 70 |
| Inventory Days | 75 | 62 | 55 | 42 |
| Payable Days | 147 | 148 | 108 | 135 |
| 0 | -11 | 29 | -24 | |
| FINANCIAL HEALTH | - | - | - | - |
| Debt to Equity (x) | 0.61x | 0.76x | 0.60x | 0.00x |
| Interest Coverage (x) | 0.32x | 1.14x | 1.70x | 6.69x |
| 1.21x | 1.16x | 1.49x | 4.19x | |
| GROWTH | - | - | - | - |
| Revenue Growth % | 0.00% | 11.51% | 10.83% | 22.85% |
| Operating Profit Growth % | 0.00% | 80.30% | 20.82% | 85.74% |
| Net Profit Growth % | 0.00% | 112.78% | 2331.91% | 36.38% |
| 0.00% | 0.00% | 2331.91% | -99.24% | |
| VALUATION | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 131.16x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 11.07x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 2.92x | 74.26x |
Mar 2022
- EPS (₹)
- -142.51
- Book Value (₹)
- 1165.06
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.88
- Operating Margin %
- 6.89%
- Net Margin %
- -3.89%
- ROE %
- -12.23%
- ROCE %
- 1.23%
- -4.15%
- Debtor Days
- 73
- Inventory Days
- 75
- Payable Days
- 147
- 0
- Debt to Equity (x)
- 0.61x
- Interest Coverage (x)
- 0.32x
- 1.21x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 18.21
- Book Value (₹)
- 923.99
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.59
- Operating Margin %
- 11.13%
- Net Margin %
- 0.45%
- ROE %
- 1.74%
- ROCE %
- 6.25%
- 0.53%
- Debtor Days
- 75
- Inventory Days
- 62
- Payable Days
- 148
- -11
- Debt to Equity (x)
- 0.76x
- Interest Coverage (x)
- 1.14x
- 1.16x
- Revenue Growth %
- 11.51%
- Operating Profit Growth %
- 80.30%
- Net Profit Growth %
- 112.78%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 442.95
- Book Value (₹)
- 1673.83
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.21
- Operating Margin %
- 8.34%
- Net Margin %
- 9.79%
- ROE %
- 34.10%
- ROCE %
- 9.07%
- 11.94%
- Debtor Days
- 82
- Inventory Days
- 55
- Payable Days
- 108
- 29
- Debt to Equity (x)
- 0.60x
- Interest Coverage (x)
- 1.70x
- 1.49x
- Revenue Growth %
- 10.83%
- Operating Profit Growth %
- 20.82%
- Net Profit Growth %
- 2331.91%
- 2331.91%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 2.92x
Mar 2025
- EPS (₹)
- 3.39
- Book Value (₹)
- 40.13
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.17
- Operating Margin %
- 15.58%
- Net Margin %
- 10.87%
- ROE %
- 13.68%
- ROCE %
- 17.68%
- 9.59%
- Debtor Days
- 70
- Inventory Days
- 42
- Payable Days
- 135
- -24
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 6.69x
- 4.19x
- Revenue Growth %
- 22.85%
- Operating Profit Growth %
- 85.74%
- Net Profit Growth %
- 36.38%
- -99.24%
- P/E (x)
- 131.16x
- P/B (x)
- 11.07x
- Dividend Yield %
- 0.00%
- 74.26x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-19 - Laxmi Dental Limited has informed the Exchange about Transcript
- Copy of Newspaper Publication
2026-08-13 - Laxmi Dental Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026